Biomedical investment and business development chatter
Science
Animal Models: A Video
One could argue this video is only a slight exaggeration of popular media explanations of results in preclinical animal models.
Share and Enjoy:
Wanna Know Why Drug Discovery/Development Is Hard?
FTY270 (fingolimod), an S1P1 modulator, is a T-cell specific immunosuppressant and is a hot, emerging phase III therapy for MS from Novartis (NVS). So where is the difficulty?
In the Aug. 14, 2008, issue of Nature, scientists from Emory University and the Yerkes Primate Research Center reported that, paradoxically, in a mouse model the drug [...]
© 2008 Pharmababble. 
Recent Comments